A federal court threw out a lawsuit requesting that the government publicly redress the harm a Medicare Advantage prescription drug plan allegedly suffered when it was terminated from and then reinstated to the Medicare program.
The US District Court for the District of Columbia on Tuesday granted the Centers for Medicare & Medicaid Services’ motion to dismiss Zing Health’s complaint that the agency’s actions materially harmed the health plan’s reputation and competitive position.
The lawsuit argued the CMS didn’t adequately atone for the reputational damage caused by Zing Health’s termination from the Medicare program after the agency abruptly revised how ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.